Glenmark Pharmaceuticals posts strong Q3 FY2025 earnings as global expansion gains momentum
Glenmark Pharmaceuticals Limited has reported a strong financial performance for the third quarter of fiscal year 2025, driven by significant growth in its India business ... Read More
Ichnos Glenmark presents data from Phase 1 study of ISB 2001 in multiple myeloma
In a presentation at the 66th American Society of Hematology Annual Meeting, Ichnos Glenmark Innovation (IGI) unveiled promising results from its Phase 1 clinical trial ... Read More